{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:23:00Z","timestamp":1790814180818,"version":"4.1.0"},"reference-count":196,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"publisher","award":["4183-00275B"],"award-info":[{"award-number":["4183-00275B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R238-2016-2708"],"award-info":[{"award-number":["R238-2016-2708"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.celrep.2022.111148","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T03:09:49Z","timestamp":1657768189000},"page":"111148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Plasmacytoid dendritic cells during COVID-19: Ally or adversary?"],"prefix":"10.1016","volume":"40","author":[{"given":"Ren\u00e9e Marije","family":"Van der Sluis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Kanstrup","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Roelsgaard","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111148_bib1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2020.01312","article-title":"The lung macrophage in SARS-CoV-2 infection: a friend or a foe?","volume":"11","author":"Abassi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","article-title":"The activation trajectory of plasmacytoid dendritic cells in\u00a0vivo during a viral infection","volume":"21","author":"Abbas","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cmi.2021.05.020","article-title":"An open-label randomized controlled trial of the effect of lopinavir\/ritonavir, lopinavir\/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19","volume":"27","author":"Ader","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.celrep.2022.111148_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41590-017-0012-z","article-title":"Diversification of human plasmacytoid predendritic cells in response to a single stimulus","volume":"19","author":"Alculumbre","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/vim.2020.0085","article-title":"Type I IFNs: a blessing in disguise or partner in crime in MERS-CoV-SARS-CoV-and SARS-CoV-2-induced pathology and potential use of type I IFNs in synergism with IFN-gamma as a novel antiviral approach against COVID-19","volume":"34","author":"Anjum","year":"2021","journal-title":"Viral Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib7","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ni736","article-title":"Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology","volume":"2","author":"Asselin-Paturel","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib9","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.4049\/jimmunol.171.12.6466","article-title":"Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody","volume":"171","author":"Asselin-Paturel","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.chom.2019.03.005","article-title":"Plasmacytoid dendritic cells and infected cells form an interferogenic synapse required for antiviral responses","volume":"25","author":"Assil","year":"2019","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.celrep.2022.111148_bib11","doi-asserted-by":"crossref","first-page":"n436","DOI":"10.1136\/bmj.n436","article-title":"Severe covid-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.celrep.2022.111148_bib12","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.celrep.2022.111148_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13238-012-2104-8","article-title":"Regulation of TLR7\/9 signaling in plasmacytoid dendritic cells","volume":"4","author":"Bao","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib14","doi-asserted-by":"crossref","first-page":"e20210554","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib15","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41467-021-21310-4","article-title":"Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections","volume":"12","author":"B\u00e9nard","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib17","doi-asserted-by":"crossref","first-page":"e1009427","DOI":"10.1371\/journal.ppat.1009427","article-title":"Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model","volume":"17","author":"Bessiere","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib18","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.76.17.8729-8736.2002","article-title":"Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling","volume":"76","author":"Bieback","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib19","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.177.5.3260","article-title":"Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation","volume":"177","author":"Blasius","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/eji.201546113","article-title":"Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway","volume":"46","author":"Bode","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib21","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","article-title":"Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells","volume":"177","author":"Boehme","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib23","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.4049\/jimmunol.169.12.6711","article-title":"Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs","volume":"169","author":"Brawand","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib25","doi-asserted-by":"crossref","first-page":"ra25","DOI":"10.1126\/scisignal.aaa1552","article-title":"Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons","volume":"8","author":"Bruni","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2022.111148_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12\u00a0months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib29","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.1117359109","article-title":"Plasmacytoid dendritic cells control T-cell response to chronic viral infection","volume":"109","author":"Cervantes-Barragan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.celrep.2022.111148_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2006-05-023770","article-title":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon","volume":"109","author":"Cervantes-Barragan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4049\/jimmunol.176.1.248","article-title":"Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells","volume":"176","author":"Chaperot","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib32","doi-asserted-by":"crossref","first-page":"e20210583","DOI":"10.1084\/jem.20210583","article-title":"Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics","volume":"218","author":"Cheemarla","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T\u00a0cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","article-title":"Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development","volume":"135","author":"Cisse","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","article-title":"Clinical manifestations of\u00a0COVID-19 in the general population: systematic review","volume":"133","author":"Da Rosa Mesquita","year":"2021","journal-title":"Wien Klin. Wochenschr."},{"key":"10.1016\/j.celrep.2022.111148_bib38","doi-asserted-by":"crossref","first-page":"e51252","DOI":"10.15252\/embr.202051252","article-title":"SARS-CoV-2 evades immune detection in alveolar macrophages","volume":"21","author":"Dalskov","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/jir.2014.0227","article-title":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections","volume":"35","author":"Davidson","year":"2015","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2022.111148_bib41","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI60945","article-title":"Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses","volume":"123","author":"Deal","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111148_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4049\/jimmunol.1800933","article-title":"Triggering of the cGAS-STING pathway in human plasmacytoid dendritic cells inhibits TLR9-mediated IFN production","volume":"205","author":"Deb","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib43","doi-asserted-by":"crossref","first-page":"e13378","DOI":"10.1111\/eci.13378","article-title":"Features of severe COVID-19: a systematic review and meta-analysis","volume":"50","author":"Del Sole","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111148_bib44","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","article-title":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets","volume":"595","author":"Delorey","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib46","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1038\/s41467-020-20139-7","article-title":"Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection","volume":"11","author":"Desai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib48","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/JVI.01578-08","article-title":"Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection","volume":"83","author":"Donaghy","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41590-019-0420-3","article-title":"Plasmacytoid dendritic cells develop from Ly6D(+) lymphoid progenitors distinct from the myeloid lineage","volume":"20","author":"Dress","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib50","doi-asserted-by":"crossref","first-page":"e67569","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2022.111148_bib51","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.4049\/jimmunol.177.9.5829","article-title":"Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production","volume":"177","author":"Fanning","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial","volume":"9","author":"Feld","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jlb.43.4.323","article-title":"Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors","volume":"43","author":"Fitzgerald-Bocarsly","year":"1988","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib54","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.4049\/jimmunol.1400215","article-title":"Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of\u00a0different composition as opposed to pDC stimulated with free virus","volume":"193","author":"Frenz","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib56","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1073\/pnas.2012520117","article-title":"Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries","volume":"117","author":"Galasso","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111148_bib57","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2008-10-183301","article-title":"Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta","volume":"114","author":"Gao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.humimm.2012.02.007","article-title":"Plasmacytoid dendritic cells and their Toll-like receptor 9 expression selectively decrease with age","volume":"73","author":"Garbe","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.celrep.2022.111148_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.20020045","article-title":"The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte\/macrophage colony-stimulating factor","volume":"195","author":"Gilliet","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.icb.7100048","article-title":"Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cells","volume":"85","author":"Grage-Griebenow","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib62","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","article-title":"Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-alpha production in women","volume":"195","author":"Griesbeck","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.185.6.1101","article-title":"The enigmatic plasmacytoid T\u00a0cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand","volume":"185","author":"Grouard","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib64","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.immuni.2021.10.009","article-title":"Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters","volume":"54","author":"Grzes","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib65","doi-asserted-by":"crossref","first-page":"729233","DOI":"10.3389\/fimmu.2021.729233","article-title":"Sex differences in primary HIV infection: revisiting the role of TLR7-driven type 1 IFN production by plasmacytoid dendritic cells in women","volume":"12","author":"Guery","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib67","doi-asserted-by":"crossref","first-page":"e01538-20","DOI":"10.1128\/JVI.01538-20","article-title":"Plasmacytoid dendritic cells mediate control of Ross River virus infection via a type I interferon-dependent, MAVS-independent mechanism","volume":"95","author":"Haist","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib68","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/j.1460-2075.1992.tb05239.x","article-title":"Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3)","volume":"11","author":"Hara","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.111148_bib69","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1073\/pnas.0707244104","article-title":"HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha","volume":"104","author":"Hardy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111148_bib70","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1038\/s41467-021-27318-0","article-title":"Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2","volume":"12","author":"Hatton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib72","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2005-07-2709","article-title":"Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells","volume":"107","author":"Ito","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib73","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41467-021-22177-1","article-title":"Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial","volume":"12","author":"Jagannathan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib75","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S2213-2600(21)00384-2","article-title":"Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib76","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1086\/425425","article-title":"Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection","volume":"190","author":"Kanto","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111148_bib77","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.4049\/jimmunol.1401541","article-title":"The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions","volume":"193","author":"Karrich","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib78","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","article-title":"Innate immune sensing of coronavirus and viral evasion strategies","volume":"53","author":"Kasuga","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.04.010","article-title":"Cell type-specific involvement of RIG-I in antiviral response","volume":"23","author":"Kato","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111148_bib81","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cmi.2020.04.040","article-title":"Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19","volume":"26","author":"Kim","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.celrep.2022.111148_bib82","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/eji.201343806","article-title":"Self-priming determines high type I IFN production by plasmacytoid dendritic cells","volume":"44","author":"Kim","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib83","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib85","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","article-title":"Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia","volume":"54","author":"Kreutmair","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib86","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.20021091","article-title":"Interferon-producing cells fail to induce proliferation of naive T\u00a0cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T\u00a0cells","volume":"197","author":"Krug","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib87","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/iid3.402","article-title":"Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity","volume":"9","author":"Kulkarni-Munje","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.celrep.2022.111148_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2007.07.013","article-title":"Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses","volume":"27","author":"Kumagai","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib89","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2018587118","article-title":"Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity","volume":"118","author":"Kvedaraite","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111148_bib90","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib91","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1038\/s41467-018-05816-y","article-title":"Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib92","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib93","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.1136880","article-title":"Autophagy-dependent viral recognition by plasmacytoid dendritic cells","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib94","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib95","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1128\/JVI.00295-12","article-title":"Herpes simplex virus glycoproteins gH\/gL and gB bind Toll-like receptor 2, and soluble gH\/gL is sufficient to activate NF-kappaB","volume":"86","author":"Leoni","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib96","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.celrep.2019.11.042","article-title":"Integrated cross-species analysis identifies a conserved transitional dendritic cell population","volume":"29","author":"Leylek","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib97","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cmet.2021.06.007","article-title":"Interferon-alpha-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T\u00a0cells during obesity","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2022.111148_bib98","doi-asserted-by":"crossref","first-page":"eabi9007","DOI":"10.1126\/sciimmunol.abi9007","article-title":"Pharmacological activation of STING blocks SARS-CoV-2 infection","volume":"6","author":"Li","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib99","doi-asserted-by":"crossref","first-page":"781432","DOI":"10.3389\/fimmu.2021.781432","article-title":"Single-cell analysis reveals the immune characteristics of myeloid cells and memory T\u00a0cells in recovered COVID-19 patients with different severities","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib101","doi-asserted-by":"crossref","first-page":"e3000849","DOI":"10.1371\/journal.pbio.3000849","article-title":"In\u00a0vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age","volume":"18","author":"Lieberman","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib103","doi-asserted-by":"crossref","first-page":"e0233521","DOI":"10.1128\/mBio.02335-21","article-title":"SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS to evade the innate immune response","volume":"12","author":"Liu","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2022.111148_bib104","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00036307","article-title":"Airway dendritic cell phenotypes in inflammatory diseases of the human lung","volume":"30","author":"Lommatzsch","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.celrep.2022.111148_bib105","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.celrep.2022.111148_bib106","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.immuni.2021.05.006","article-title":"SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2","volume":"54","author":"Lu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib107","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15252\/embr.201439366","article-title":"Positive feedback regulation of type I interferon by the interferon-stimulated gene STING","volume":"16","author":"Ma","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib109","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.immuni.2018.03.020","article-title":"Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection","volume":"48","author":"Macal","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib110","doi-asserted-by":"crossref","first-page":"155151","DOI":"10.1016\/j.cyto.2020.155151","article-title":"COVID-19 cytokine storm: the anger of inflammation","volume":"133","author":"Mahmudpour","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2022.111148_bib111","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41435-021-00157-1","article-title":"Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients","volume":"23","author":"Mantovani","year":"2022","journal-title":"Genes Immun."},{"key":"10.1016\/j.celrep.2022.111148_bib113","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fimmu.2013.00372","article-title":"Human plasmacytoid dendritic cells: from molecules to intercellular communication network","volume":"4","author":"Mathan","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib114","doi-asserted-by":"crossref","first-page":"e0241097","DOI":"10.1371\/journal.pone.0241097","article-title":"SARS-CoV-2 infection induces mixed M1\/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets","volume":"15","author":"Matic","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111148_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","article-title":"Plasmacytoid dendritic cells: linking innate and adaptive immunity","volume":"79","author":"Mckenna","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"Mcnab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib117","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib118","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","article-title":"Immune evasion of SARS-CoV-2 from interferon antiviral system","volume":"19","author":"Min","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.celrep.2022.111148_bib119","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib120","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3389\/fimmu.2020.02037","article-title":"The immune response and immunopathology of COVID-19","volume":"11","author":"Mortaz","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib122","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ni1522","article-title":"Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Naik","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib123","doi-asserted-by":"crossref","first-page":"647824","DOI":"10.3389\/fimmu.2021.647824","article-title":"Macrophages and dendritic cells are not the major source of pro-inflammatory cytokines upon SARS-CoV-2 infection","volume":"12","author":"Niles","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib124","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.2000892","article-title":"Immune response resetting as a novel strategy to overcome SARS-CoV-2-induced cytokine storm","volume":"205","author":"Nowill","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib125","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41467-018-04686-8","article-title":"Mitochondrial reactive oxygen species regulate the induction of CD8(+) T\u00a0cells by plasmacytoid dendritic cells","volume":"9","author":"Oberkampf","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib126","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","article-title":"Age-specific mortality and immunity patterns of SARS-CoV-2","volume":"590","author":"O'driscoll","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib127","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/cells10030530","article-title":"SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response","volume":"10","author":"Oh","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2022.111148_bib128","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni1518","article-title":"Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow","volume":"8","author":"Onai","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib129","doi-asserted-by":"crossref","first-page":"e20201387","DOI":"10.1084\/jem.20201387","article-title":"SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4","volume":"218","author":"Onodi","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib130","doi-asserted-by":"crossref","first-page":"e1005546","DOI":"10.1371\/journal.ppat.1005546","article-title":"cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells","volume":"12","author":"Paijo","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib132","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41423-021-00728-2","article-title":"Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection","volume":"18","author":"P\u00e9rez-G\u00f3mez","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib133","first-page":"120","article-title":"A leukocyte subset bearing HLA-DR antigens is responsible for in\u00a0vitro alpha interferon production in response to viruses","volume":"4","author":"Perussia","year":"1985","journal-title":"Nat. Immun. Cell Growth Regul."},{"key":"10.1016\/j.celrep.2022.111148_bib134","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/imm.13254","article-title":"Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection","volume":"161","author":"Peruzzi","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2022.111148_bib135","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2008-10-186890","article-title":"Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation","volume":"113","author":"Piccioli","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib136","doi-asserted-by":"crossref","first-page":"e3000209","DOI":"10.1371\/journal.pbio.3000209","article-title":"TLR1\/2 orchestrate human plasmacytoid predendritic cell response to gram+ bacteria","volume":"17","author":"Raieli","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib137","doi-asserted-by":"crossref","first-page":"e145853","DOI":"10.1172\/JCI145853","article-title":"Identification of SARS-CoV-2-specific immune alterations in acutely ill patients","volume":"131","author":"R\u00e9billard","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111148_bib139","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41590-018-0136-9","article-title":"Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells","volume":"19","author":"Rodrigues","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib140","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.3390\/ijerph17165974","article-title":"The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression","volume":"17","author":"Romero Starke","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.celrep.2022.111148_bib141","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/eji.1830130608","article-title":"Properties of human natural interferon-producing cells stimulated by tumor cell lines","volume":"13","author":"R\u00f6nnblom","year":"1983","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib142","doi-asserted-by":"crossref","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib143","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41556-021-00681-2","article-title":"Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity","volume":"23","author":"Saichi","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib144","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1038\/s41598-021-92940-3","article-title":"The RNA sensor MDA5 detects SARS-CoV-2 infection","volume":"11","author":"Sampaio","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib145","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1172\/JCI140335","article-title":"COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes","volume":"130","author":"Sanchez-Cerrillo","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111148_bib146","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib147","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib148","doi-asserted-by":"crossref","first-page":"eaag3009","DOI":"10.1126\/science.aag3009","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","volume":"356","author":"See","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib149","doi-asserted-by":"crossref","first-page":"e1009878","DOI":"10.1371\/journal.ppat.1009878","article-title":"Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection","volume":"17","author":"Severa","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib150","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00355.2020","article-title":"High-dimensional single-cell analysis reveals the immune characteristics of COVID-19","volume":"320","author":"Shi","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.celrep.2022.111148_bib151","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib152","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jmv.27317","article-title":"The role of type I interferon in the treatment of COVID-19","volume":"94","author":"Sodeifian","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib153","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib154","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T\u00a0cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib156","doi-asserted-by":"crossref","first-page":"e1003728","DOI":"10.1371\/journal.ppat.1003728","article-title":"Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections","volume":"9","author":"Swiecki","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib157","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/icb.2014.38","article-title":"TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner","volume":"92","author":"Szabo","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib158","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2011.10.014","article-title":"Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T\u00a0cell immunity in\u00a0vivo","volume":"35","author":"Takagi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib159","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.111148_bib161","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.4049\/jimmunol.0903286","article-title":"Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen","volume":"184","author":"Tel","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib162","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood-2012-06-435644","article-title":"Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T\u00a0cells despite lower Ag uptake than myeloid dendritic cell subsets","volume":"121","author":"Tel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib163","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1128\/JVI.01501-14","article-title":"Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens","volume":"88","author":"Thomas","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib164","doi-asserted-by":"crossref","first-page":"e107826","DOI":"10.15252\/embj.2021107826","article-title":"SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation","volume":"40","author":"Thorne","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.111148_bib165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.20592","article-title":"Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection","volume":"41","author":"Ulsenheimer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2022.111148_bib166","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.celrep.2019.12.096","article-title":"Human pDCs are superior to cDC2s in attracting cytolytic lymphocytes in melanoma patients receiving DC vaccination","volume":"30","author":"Van Beek","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib167","doi-asserted-by":"crossref","first-page":"e109622","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"Van Der Sluis","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.111148_bib169","doi-asserted-by":"crossref","first-page":"672729","DOI":"10.3389\/fimmu.2021.672729","article-title":"Phenotypical diversification of early IFNalpha-producing human plasmacytoid dendritic cells using droplet-based microfluidics","volume":"12","author":"Van Eyndhoven","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib170","doi-asserted-by":"crossref","first-page":"e00985-20","DOI":"10.1128\/JVI.00985-20","article-title":"Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures","volume":"94","author":"Vanderheiden","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib171","doi-asserted-by":"crossref","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib172","doi-asserted-by":"crossref","first-page":"109773","DOI":"10.1016\/j.celrep.2021.109773","article-title":"Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity","volume":"37","author":"Vono","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib173","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41556-021-00685-y","article-title":"Monocyte and dendritic cell defects in COVID-19","volume":"23","author":"Wack","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111148_bib174","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801","volume":"591","author":"Wahl","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib176","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.4049\/jimmunol.177.9.6263","article-title":"Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection","volume":"177","author":"Wang","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib177","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1172\/JCI145301","article-title":"Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum","volume":"130","author":"Weatherhead","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111148_bib178","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3389\/fimmu.2018.03167","article-title":"Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration","volume":"9","author":"Webb","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib179","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib180","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41467-018-05784-3","article-title":"Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells","volume":"9","author":"Wimmers","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111148_bib181","doi-asserted-by":"crossref","first-page":"e1009742","DOI":"10.1371\/journal.ppat.1009742","article-title":"Impaired function and delayed regeneration of dendritic cells in COVID-19","volume":"17","author":"Winheim","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111148_bib182","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41577-021-00656-2","article-title":"Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses - are we our own worst enemy?","volume":"22","author":"Wong","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib183","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib184","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41421-020-00225-2","article-title":"The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing","volume":"6","author":"Xu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.celrep.2022.111148_bib185","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41590-021-00942-0","article-title":"RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells","volume":"22","author":"Yamada","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib186","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111148_bib187","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2008.07.009","article-title":"Structural mechanism of RNA recognition by the RIG-I-like receptors","volume":"29","author":"Yoneyama","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib188","doi-asserted-by":"crossref","first-page":"eabc7302","DOI":"10.1126\/sciimmunol.abc7302","article-title":"Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells","volume":"6","author":"Yun","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib189","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2021.08.004","article-title":"Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?","volume":"50","author":"Zanoni","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.celrep.2022.111148_bib190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib191","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111148_bib192","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/jiaa753","article-title":"Severe acute respiratory syndrome coronavirus 2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells","volume":"223","author":"Zheng","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111148_bib193","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib194","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111148_bib195","doi-asserted-by":"crossref","first-page":"615275","DOI":"10.3389\/fimmu.2020.615275","article-title":"Interferon-alpha2b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib196","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T\u00a0cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111148_bib197","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2006-06-027136","article-title":"Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111148_bib198","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111148_bib199","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111148_bib200","doi-asserted-by":"crossref","first-page":"627548","DOI":"10.3389\/fimmu.2021.627548","article-title":"Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia","volume":"12","author":"Zingaropoli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111148_bib201","doi-asserted-by":"crossref","first-page":"760288","DOI":"10.3389\/fimmu.2021.760288","article-title":"Obesity correlates with pronounced aberrant innate immune responses in hospitalized aged COVID-19 patients","volume":"12","author":"Zulu","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722009573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722009573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:42:38Z","timestamp":1762602158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722009573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":196,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2211124722009573"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111148","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmacytoid dendritic cells during COVID-19: Ally or adversary?","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111148"}}